BUZZ-CVS rises after UBS upgrades on healthcare benefits recovery

Reuters
08/18
BUZZ-CVS rises after UBS upgrades on healthcare benefits recovery 

** Brokerage UBS upgrades healthcare conglomerate CVS Health CVS.N to "buy" from "neutral," raising PT to $79 from $67

** New PT represents a ~13.2% upside to the stock's last close

** Shares of CVS up 2.2% at $70.1 premarket

** UBS says CVS has managed its Medicare Advantage plans well, giving the brokerage more confidence in its future performance

** UBS believes CVS will reduce its debt by late 2026, allowing for more share buybacks and further earnings growth

** UBS says it does not expect any major negative changes from drug pricing rules or its Star ratings in the near term

** As of last close, CVS stock up 52.8% YTD

(Reporting by Padmanabhan Ananthan)

((Padmanabhan.Ananthan@thomsonreuters.com))

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10